GD Brisson, LR Alves… - …, 2015 - ncbi.nlm.nih.gov
Acute leukaemias (AL) correspond to 25–35% of all cancer cases in children. The aetiology is still sheltered, although several factors are implicated in causality of AL subtypes …
Background Heroin dependence is a debilitating psychiatric disorder with complex inheritance. Since the dopaminergic system has a key role in rewarding mechanism of the …
M Hegyi, A Arany, AF Semsei, K Csordas, O Eipel… - …, 2016 - pmc.ncbi.nlm.nih.gov
Inter-individual differences in toxic symptoms and pharmacokinetics of high-dose methotrexate (MTX) treatment may be caused by genetic variants in the MTX pathway …
Although substantial advances in the identification of cytogenomic subtypes of childhood acute lymphoblastic leukemia (ALL) have been made in recent decades, epidemiologic …
A Gutierrez-Camino, I Martin-Guerrero, A García-Orad - Medical Oncology, 2017 - Springer
Acute lymphoblastic leukemia (ALL) is the most common childhood malignancy and a leading cause of death due to disease in children. The genetic basis of ALL susceptibility …
P Wang, Y Deng, X Yan, J Zhu, Y Yin, Y Shu… - Frontiers in …, 2020 - frontiersin.org
Acute lymphoblastic leukemia (ALL) is the most common malignancy in children with distinct characteristics among different subtypes. Although the etiology of ALL has not been fully …
N Kutszegi, X Yang, A Gézsi, G Schermann… - …, 2017 - ncbi.nlm.nih.gov
Hypersensitivity reactions are the most frequent dose-limiting adverse reactions to Escherichia coli-derived asparaginase in pediatric acute lymphoblastic leukemia (ALL) …
In this study we investigated whether polymorphisms in the folate pathway influenced the risk of childhood acute lymphoblastic leukemia (ALL) or the survival rate of the patients. For …
K Csordas, O Lautner‐Csorba… - British journal of …, 2014 - Wiley Online Library
High‐dose methotrexate (HD‐MTX) plays an important role in the consolidation therapy of acute lymphoblastic leukaemia (ALL) in many treatment regimens worldwide. However …